Bottom line
How much do XBI and FBIOX overlap?
20% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 9.6% of XBI's assets and 21.5% of FBIOX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings XBI and FBIOX have in common
| Holding | % of XBI | % of FBIOX | Overlap |
|---|---|---|---|
| Moderna Inc | 1.41% | 1.28% | 1.28% |
| Praxis Precision Medicines Inc | 1.29% | 2.47% | 1.29% |
| Revolution Medicines Inc | 1.20% | 2.02% | 1.20% |
| Natera Inc | 1.16% | 1.41% | 1.16% |
| Scholar Rock Holding Corp | 1.16% | 1.55% | 1.16% |
| Roivant Sciences Ltd | 1.16% | 1.13% | 1.13% |
| Cogent Biosciences Inc | 1.14% | 1.07% | 1.07% |
| Krystal Biotech Inc | 1.10% | 10.58% | 1.10% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XBI
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Erasca Inc — 1.27%
- Rhythm Pharmaceuticals Inc — 1.20%
- CG oncology Inc — 1.20%
- SELLAS Life Sciences Group Inc — 1.19%
- Vaxcyte Inc — 1.19%
- Dianthus Therapeutics Inc — 1.18%
- Cytokinetics Inc — 1.18%
- Mirum Pharmaceuticals Inc — 1.16%
- Ultragenyx Pharmaceutical Inc — 1.14%
Only in FBIOX
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Axsome Therapeutics Inc — 1.28%
- Biogen Inc — 1.26%
- Protagonist Therapeutics Inc — 1.15%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
Asset mix
| Asset type | XBI | FBIOX |
|---|---|---|
| Stocks | 99.9% | 99.0% |
| Cash & short-term funds | 5.9% | 3.5% |
| Preferred stock | — | 0.9% |
| Equity derivatives | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | XBI | FBIOX |
|---|---|---|
| US | 100.8% | 88.5% |
| NL | 1.0% | 2.9% |
| DK | — | 2.6% |
| BE | — | 2.0% |
| IE | 1.2% | 2.0% |
| BM | 1.2% | 1.1% |
| CH | 1.0% | 1.1% |
| FR | — | 0.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do XBI and FBIOX overlap?
What stocks do XBI and FBIOX have in common?
Should I own both XBI and FBIOX?
Which holds more stocks, XBI or FBIOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.